Skip to content
healthcare.dev

GABAPENTIN

NDC 69097-815, GABAPENTIN, capsule, from Cipla USA Inc..

Product NDC
69097-815
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090705
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-815 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN400 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
69097-815-0769097081507100 CAPSULE in 1 BOTTLE (69097-815-07)
69097-815-1269097081512500 CAPSULE in 1 BOTTLE (69097-815-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9e4eca9c-6a2c-4ede-a252-1a27094bf594
  • NADAC price for package 69097081507

    GET /v1/drugs/nadac/69097081507

Use it

Look up 69097-815 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-815 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-815. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.